Z-2650-2014 Class III Terminated
FDA device recall Z-2650-2014 was initiated by Diagnostica Stago, Inc. on Jul 18, 2014 and is designated Class III. Reason for recall: Diagnostica Stago Inc. received some customer complaints regarding a misreading of Reagent 1 (substrate) barcode on STA analyzers. The recall status is terminated (terminated Jan 16, 2015). Affected quantity: 514 kits.
Recall details
- Product Type
- Devices
- Report Date
- Sep 24, 2014
- Initiation Date
- Jul 18, 2014
- Termination Date
- Jan 16, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 514 kits
Product description
Stago IVD, Liquid Anti-Xa, NDC 3607450003116. The STA - Liquid Anti-Xa kits are intended for use with STA-R, STA Compact and STA Satellite Analyzers for the quantitative determination of the plasma levels of unfractionated (UFH) and low molecular weight (LMWH) heparins by measuring their anti-Xa activity on antithrombin in a competitive assay using a synthetic chromogenic substrate.
Reason for recall
Diagnostica Stago Inc. received some customer complaints regarding a misreading of Reagent 1 (substrate) barcode on STA analyzers.
Distribution pattern
Distributed USA (nationwide) and the country of Canada.
Code information
510(k) #K111822, Lot #112366, Part # REF 00311US
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2650-2014
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026